Nosh Biofoods is a technology company.
Nosh Biofoods has raised $7.0M across 2 funding rounds.
Nosh Biofoods has raised $7.0M in total across 2 funding rounds.
Nosh Biofoods has raised $7.0M in total across 2 funding rounds.
Nosh Biofoods's investors include Andreessen Horowitz, Clear Current Capital, Earlybird Venture Capital, Target Partners, Visionaries Club, Victor Jacobsson.
Nosh.bio (also referred to as Nosh Biofoods in some contexts) is a Berlin-based B2B biotech startup founded in 2022, specializing in producing nutritional and functional proteins from non-GMO fungi via biomass fermentation, using agricultural side streams as feedstock.[1][2][4] The company develops Koji protein derived from the mycelium of *Aspergillus oryzae*, targeting meat/seafood analogs, dairy, bakery, confectionery, and hybrid applications to enhance taste, texture, nutrition, and affordability in alternative proteins.[3][5][6] It serves food manufacturers seeking scalable, sustainable ingredients that enable up to 100% inclusion without flavor masking, with current production at 5 tons/week via CMO and plans to scale to 5-10,000 tons annually by retrofitting brewery infrastructure.[2][5] Backed by Earlybird (invested 2023), Nosh.bio demonstrates strong growth momentum through rapid scaling, GRAS certification, and non-novel food status, positioning it to address alt-protein market barriers like cost and consistency.[2][3][5]
Nosh.bio was founded in early 2022 by Tim Fronzek (CEO, German entrepreneur) and Dr. Felipe Lino (Brazilian bioscientist), with Xiangdong Zhao as a key co-founder, in Berlin, Germany.[2][5][6] The idea emerged from a mission to create a self-sustaining food system by making sustainable foods affordable, nutritious, and delicious, leveraging Fronzek's business acumen and Lino's biotech expertise, supported early by strategist Alix Chausson from EVIG.[6] Pivotal early traction included securing Earlybird investment in 2023, leasing a 280,000-liter brewery for retrofitting (announced October prior to 2025), and ramping CMO production to 5 tons/week while preparing first product launches within 12 months of investment.[2][5] This multinational team (8 nationalities) humanizes a purpose-driven venture focused on non-GMO, clean-label fungi to disrupt alt-proteins without harming planet, animals, or people.[2][6]
Nosh.bio stands out in the alt-protein space through its proprietary, minimal fermentation process and versatile Koji protein. Key advantages include:
Nosh.bio rides the alt-protein and precision fermentation wave, addressing mainstream adoption hurdles like high costs, poor taste/texture, and scalability in a market projected to grow amid climate pressures and animal-free food demand.[3][6] Timing is ideal post-2022 amid investor interest in sustainable biotech (e.g., Earlybird backing), with market forces like EU green regulations and consumer shifts toward affordable hybrids favoring its non-GMO, retrofit model over capital-intensive greenfield builds.[2][5] It influences the ecosystem by enabling food giants to hit mass-market appeal—unlocking hybrids, reducing reliance on agriculture, and cutting emissions—while bridging biomass fermentation with cellular ag scalability for versatile, industrial-ready ingredients.[4][6]
Nosh.bio is poised for explosive growth, targeting 5-10,000 tons/year production by early 2026 via owned facilities and CMOs, with expansions into dairy, bakery, and confectionery beyond meat analogs.[5] Trends like cost-crushed alt-proteins, hybrid product surges, and retrofitted infra adoption will propel it, potentially dominating as the go-to B2B enabler for planet-friendly foods. Its influence may evolve into a platform leader, partnering with majors to mainstream mycelium and redefine sustainable nutrition at scale—proving biotech can make alt-proteins not just viable, but superior and irresistible.[3][6]
Nosh Biofoods has raised $7.0M across 2 funding rounds. Most recently, it raised $3.0M Seed in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $3.0M Seed | Andreessen Horowitz, Clear Current Capital, Earlybird Venture Capital, Target Partners, Visionaries Club, Victor Jacobsson | |
| Apr 1, 2023 | $4.0M Seed | Andreessen Horowitz, Earlybird Venture Capital, Target Partners, Visionaries Club, Victor Jacobsson |